Oscar Health, Inc. Stock Prediction and Forecast [OSCR]

AI-generated source summary

The analysis focuses on Oscar Health (OSCR) stock. Since September 18, 2025, the system has ranked OSCR as a strong buy candidate, with a score of 7.180. The stock has gained 16.75% since then, with an average daily gain of 1.29%. The stock is in an upward trend. For short-term traders, a pullback to the lower segment of the trend is anticipated. A breakout above the upper trendline at $22.90 would signal stronger upward momentum. The three-month trend suggests a potential change of 36.24%, with possible returns ranging from 13.92% to 39.85%. The analysis has a 12-month trend with 8.02% . The future price may fall between $13.34 and $23.64. The latest daily update indicates a close at $22.31, a 3.00% increase. Trading volume decreased, and a medium risk is given. All the analysts give it a Sell Rating. Fibonacci shows no resistance, and a support of $21.66. Our recommended stop-loss is set at $21.65, or 2.98%. The recommendation is to monitor trading with target opening price at 21.95.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   07 Oct 2025, 03:49 UTC

   The analyst published the original source item.

2. First prediction resolved

   07 Oct 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   07 Oct 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.